Browse treatments

…or the significant association between hospitalization risk and combination therapy versus SGLT2i monotherapy, the corresponding E value was 1.36. …

…was calculated and subsequently subdivided into monotherapy and combination therapy. The prescription frequency of the most common antidiabetic dru…

…carcinoma) had received five prior lines of treatment including chemotherapy, anti-epidermal growth factor receptor, anti-PD-L1 and investig…

…ivo restimulation assays and single-cell RNA sequencing.Results Combination therapy induced dense intratumoral clusters of CD4 + and CD8+ T cells, …

…lready on treatment with macitentan and/or selexipag as part of combination therapy. A dedicated narrative collection was carried out within the la…

…inly for respiratory (21.9%) and urinary tract infections (8%). Combination therapy was used in 26.7% of prescriptions, mainly for synergistic purp…

…afety, pharmacokinetics, immunogenicity and pharmacodynamics of combination therapy with nipocalimab and certolizumab in participants with active r…

…2 anti-dsDNA has recently emerged as a biomarker of response to combination therapy in systemic lupus erythematosus (SLE). We sought to investigate…

… treatment approach for these MDR infections remains uncertain. Combination therapy has shown promise in treating other MDR pathogens by enhancing …

…justing for age, sex, WHO functional class (III/IV vs I/II) and PAH-targeted therapy, PAH-targeted therapy was independently associated with improve…

…notherapies, with further significant enhancement observed with combination therapy. These antitumor effects were not significantly reduced under C…

…ors, we assessed anti-tumor activity and survival benefit after combination therapy. To determine the requirement of a subset of immune cells (NK c…